27.95
Uniqure N V Borsa (QURE) Ultime notizie
Will uniQure N.V. stock deliver shareholder value2025 Retail Activity & AI Driven Price Forecasts - newser.com
Is uniQure N.V. (UQ1) stock supported by strong fundamentalsJuly 2025 Movers & High Accuracy Swing Entry Alerts - newser.com
uniQure N.V. (QURE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - FinancialContent
Summers Value Partners Established a Position in UniQure N.V. (QURE) in Q3 - Insider Monkey
Can uniQure N.V. (UQ1) stock sustain revenue momentumQuarterly Earnings Summary & Detailed Earnings Play Strategies - newser.com
Why uniQure N.V. (UQ1) stock is trending on social media2025 Geopolitical Influence & Safe Investment Capital Preservation Plans - newser.com
Is uniQure N.V. stock a buy on dipsTrade Performance Summary & Risk Controlled Swing Alerts - newser.com
Predicting uniQure N.V. trend using moving averagesQuarterly Profit Summary & Real-Time Buy Zone Alerts - newser.com
Do Rising Losses at uniQure (QURE) Reflect Strategic Investment or Escalating Cost Pressure? - simplywall.st
Hemophilia B Research Report 2025-2035: Market Led by UniQure, Pfizer, Novo Nordisk, HEMA Biologics, and Alnylam Pharmaceuticals as Next-Generation Therapies and R&D Investment Drive Innovation - Yahoo Finance
How currency fluctuations impact uniQure N.V. stockMarket Sentiment Report & Real-Time Volume Analysis - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating uniQure N.V. (QURE) And Encourages Shareholders to Connect - ACCESS Newswire
Wall Street Has a Positive Outlook on uniQure N.V. (QURE) Despite Challenges From The FDA - MSN
What data driven models say about uniQure N.V.’s futureQuarterly Trade Report & Expert Verified Stock Movement Alerts - newser.com
Volatility clustering patterns for uniQure N.V.Weekly Stock Report & High Accuracy Swing Entry Alerts - newser.com
How to read the order book for uniQure N.V.2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Risk adjusted return profile for uniQure N.V. analyzedJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
uniQure N.V. Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - FinancialContent
uniQure NV Hits Day High with 15.18% Surge Amid Market Volatility - Markets Mojo
uniQure N.V. (NASDAQ:QURE) Analysts Just Slashed Next Year's Revenue Estimates By 26% - Yahoo Finance
Can uniQure N.V. stock hit analyst price targetsJuly 2025 Selloffs & Verified Momentum Stock Ideas - newser.com
UniQure N.V. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsQURE - 富途牛牛
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
How institutional buying supports uniQure N.V. stock2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - newser.com
What catalysts could drive uniQure N.V. stock higherJuly 2025 Institutional & Scalable Portfolio Growth Methods - newser.com
Why uniQure N.V. stock is rated strong buyWeekly Gains Report & Verified Entry Point Detection - Fundação Cultural do Pará
uniQure (QURE) Surges 17.9% Ahead of 2 Health Conferences - MSN
NASDAQ: QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - NewMediaWire
FDA Unveils New Path for Approving Rare Disease Drugs for Just One Person - Bloomberg.com
Makary, Prasad outline pathway for bespoke gene therapy - statnews.com
Uniqure’s CEO dined with investors. Here’s what he said - statnews.com
Analysts Have Lowered Expectations For uniQure N.V. (NASDAQ:QURE) After Its Latest Results - Yahoo Finance
NASDAQ: QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - NewMediaWire
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):